RN7SL854P

Across TCGA pan-cancer cohorts, RN7SL854P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL854P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RN7SL854P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL854P expression acts as an unfavorable survival marker, although some lineages such as BRCA and OV show a favorable association.

LIHC, ACC, and THYM are the cancer types where RN7SL854P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.135	0.550	<.001	102	view →
ACC	OS	Tertile	All	0.122	0.640	<.001	63	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
BLCA	OS	Tertile	III,IV	0.141	0.581	.011	18	view →
BRCA	OS	Tertile	All	1.000	0.921	.047	6	view →
OV	OS	Tertile	III,IV	0.920	0.676	.048	6	view →
KIRP	OS	Tertile	All	0.212	0.708	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL854P–LIHC (DFS)

Open the LIHC breakdown →